Incidence and role of apoptosis in myelodysplastic syndrome: morphological and ultrastructural assessment

Leukemia
A D BogdanovićM D Colović

Abstract

By application of morphological and ultrastructural methods for identification of apoptosis, we analyzed the incidence of morphologically evident apoptosis in the bone marrow of 30 patients with myelodysplastic syndrome (MDS), and in the bone marrow of 12 healthy individuals. According to FAB classification, out of 30 patients, eight (26.6%) had refractory anemia, three (10%) had refractory anemia with ringed sideroblasts, 14 (46.6%) had refractory anemia with excess of blasts and two (6.8%) had refractory anemia with excess of blasts in transformation. Three patients (10%) had chronic myelomonocytic leukemia. Cells in apoptosis were examined on semithin slides and expressed as the apoptotic index (AI) (percent counted on at least 1000 cells). An overall increase in apoptosis in patients with MDS was found (median AI in patients vs controls, 3.13% vs 1.05%, P < 0.01 by Mann-Whitney U test). Also, negative correlation between AI and white blood cell count was found (linear r= -0.53, or Spearman rank R= -0.52, both P < 0.01). In patients with evident karyotype changes AI was not higher than in patients with normal karyotype. This suggests that discrete alterations in apoptosis are present even in karyotypically 'normal' clones. O...Continue Reading

Citations

Aug 16, 2001·International Journal of Hematology·Jane E Parker, Ghulam J Mufti
Oct 12, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Youshan ZhaoChunkang Chang
Jun 9, 2004·Developmental and Comparative Immunology·Francesca CimaLoriano Ballarin
Sep 4, 1999·Leukemia Research·Y Yoshida, G J Mufti
Oct 16, 2002·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Loriano BallarinArmando Sabbadin
Jun 3, 1998·British Journal of Haematology·J E Parker, G J Mufti
Mar 13, 2010·Future Oncology·Florian Nolte, Wolf-K Hofmann
Mar 14, 2000·Medical Oncology·A A van de Loosdrecht, E Vellenga
Aug 13, 2008·Ultrastructural Pathology·John A Terzakis, Metin Taskin
Jul 12, 2002·American Journal of Hematology·Delphine BoudardLydia Campos
Nov 3, 2007·Experimental Hematology·Daniella B Kerbauy, H Joachim Deeg
May 9, 2007·Leukemia Research·Yumiko ShioiKiyoyuki Ogata
Jan 16, 2007·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Kiyoyuki Ogata
Nov 10, 2000·The Journal of Veterinary Medical Science·M HisasueH Tsujimoto
Mar 5, 2013·Leukemia Research·Matheus Rodrigues LopesPatricia Favaro
Jan 1, 1998·Hematology·D J Culligan
Jun 28, 2001·Leukemia & Lymphoma·J E Parker, G J Mufti
Oct 12, 2004·European Journal of Clinical Investigation·M VoulgarelisA G Tzioufas
May 20, 2016·Journal of Ophthalmic & Vision Research·Hassan GhasemiMohammad Ebrahim Yarmohammadi
Jul 7, 2020·Frontiers in Immunology·Luana Chiquetto Paracatu, Laura G Schuettpelz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.